Cyient Q3 Results Review - FY24 Revenue Guidance Cut On Expected Lines: Motilal Oswal

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy..Motilal Oswal Report.Cyient Ltd.’s service segment was hit by near-term challenges, while the long-term prospects still remain constructive. Additionally, the macro recovery should contribute incrementally to its overall growth in FY25E/FY26E. On an SOTP basis, we are valuing its stake in DLM at market valuation with a holding company discount of 25%. We value the digital, engineering and technology business at 23 times our FY26E earnings. We broadly keep our FY25/FY26 consolidated profit after tax estimates unchanged. We maintain our 'Buy' rating on the stock on attractive valuations. Our SOTP-based target price of Rs 2,400 implies an upside potential of 19%..Click on the attachment to read the full report:.Cyient DLM Q3 Results Review - Growth Uninterrupted; Another Strong Quarter: Motilal Oswal.DISCLAIMERThis report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Cyient Q3 Results Review - FY24 Revenue Guidance Cut On Expected Lines: Motilal Oswal

Strong Q3 deal wins positive for FY25E growth

Choose a plan